US 2013/0011426 A1 · Recombinant Vaccines and Use Thereof

Abstract

The present invention relates to fusion molecules of antigens, the nucleic acids coding therefor and the use of such fusion molecules and nucleic acids. In particular, said invention relates to fusion molecules, comprising an antigen and the trans-membrane region and cytoplasmic region of a MHC molecule and/or the cytoplasmic region of a MHC or a SNARE molecule.

Claims24

Dependent claims

A fusion protein, which comprises an antigen, a transmembrane region, and a cytoplasmic region of a chain of an MHC molecule.

Dependencies are inferred from the claim text.

Facts

Application

13/471,606Filed 15 May 2012

Priority

DE 103 47 710.114 Oct 2003

Published

10 Jan 2013

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

A61K 47/64
The modifying agent being a protein, peptide or polyamino acid: drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the
A61P 31/14
Antivirals: for RNA viruses

Abstract

Claims24

Dependent claims

A fusion protein, which comprises an antigen, a transmembrane region, and a cytoplasmic region of a chain of an MHC molecule.

Dependencies are inferred from the claim text.

Recombinant Vaccines and Use Thereof

Life of this patent

Abstract

Claims24

Recombinant Vaccines and Use Thereof

Life of this patent

Abstract

Claims24